IDEXX Laboratories' CEO, Mike Erickson, commented on the company's scaling strategy and announced the rollout of new diagnostic services.
3 reports, 2 independent
Updated Aug 11
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
IDEXX Laboratories' CEO, Mike Erickson, commented on the company's scaling strategy and announced the rollout of new diagnostic services.
Who's involved
What this event is mainly aboutMike Erickson
How it developed
Newest first. Tap a step to see who reported it.IDEXX launched the Catalyst proBNP Test as part of its new diagnostic service rollout.1 source
- IDEXX customers are shifting pancreatic lipase testing to the Catalyst instrument platform.Sub-event
IDEXX CEO discussed scaling strategy and announced new diagnostic service rollouts.1 source